Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Everpure CEO Charles H. Giancarlo Sells $7.05M of Stock
Charles H. Giancarlo, CEO, sold 70,000 shares of Everpure, Inc. at $98.93 to $104.64 a share (average $100.77) in 7 transactions, worth $7.05M in total on Nov 10, 2026. Shares held after the trade: 1,369,735 (-0.0%).
DiaMedica Therapeutics reported Q3 2026 financial results and provided clinical updates on its DM199 programs. The company completed enrollment in the first two cohorts of its Phase 2 fetal growth restriction (FGR) trial and surpassed the 200-participant enrollment threshold for its ReMEDy2 Phase 2/3 acute ischemic stroke trial, with an interim analysis expected in Q1 2027.
Term
Q3 2026
“During the third quarter and recent weeks, we continued to advance DM199 across each of our clinical programs, including completing enrollment in the first two cohorts of our Phase 2 early-onset fetal growth restriction study and reaching the 200-participant enrollment threshold for the planned interim analysis of ReMEDy2.”
Rick Pauls, President and Chief Executive Officer
“Our clinical programs are providing important opportunities to evaluate the pharmacologic effects of DM199 across pregnancy-related vascular disorders and acute ischemic stroke.”
Mountain Crest Acquisition Corp. V Other 8-K Filing
Mountain Crest Acquisition Corp. V stockholders approved an amendment to the company's charter to extend the deadline for completing an initial business combination to May 16, 2027. In connection with the vote, stockholders redeemed 64,297 shares of common stock.
Ecolab Insider David MacLennan Buys $185K of Stock
David MacLennan bought 600 shares of Ecolab Inc. at $308.12 a share, worth $185K in total on Nov 12, 2026. Shares held after the trade: 26,225 (+2.3%).
Sidus Space announced that its financial statements for the fiscal years 2024 and 2025, along with several quarterly reports through mid-2026, should no longer be relied upon. The company intends to restate these affected financial statements in a comprehensive amendment to its 2025 Annual Report and its Q3 2026 Quarterly Report. This non-reliance determination was made by the Audit Committee and management due to identified accounting errors.
CapsoVision reported a net revenue of $10.0 million for the nine months ended September 30, 2026, a slight increase from $9.6 million in the prior year. However, the company experienced a net loss of $21.9 million during this period, driven by high research and development expenses as they pursue FDA clearances for new products like the CapsoCam Colon capsule and AI capabilities.
Veralto SVP, Water Quality Melissa Kapity Sells $608K of Stock
Melissa Kapity, SVP, Water Quality, sold 5,146 shares of Veralto Corp at $118.06 a share, worth $608K in total on Nov 10, 2026. Shares held after the trade: 14,715 (-25.9%).
Aaron Saltz, CLO, sold 9,597 shares of Magnite, Inc. at $28.75 a share, worth $276K in total on Nov 9, 2026. Shares held after the trade: 214,792 (-4.3%).
T1 Energy Inc. reported a significant increase in total net sales to $624.4 million for the nine months ended September 30, 2026, driven largely by related party transactions. Despite the revenue growth, the company incurred a net loss of $104.5 million for the period, though this was an improvement from the $178.7 million loss in the prior year.
As of September 30, 2026, Blackstone Private Credit Fund reported total assets of $79.1 billion and total net assets of $41.1 billion, reflecting a decrease from $47.6 billion at year-end 2025. The fund's investment portfolio is primarily composed of non-controlled/non-affiliated investments valued at $71.3 billion, supported by $34.2 billion in debt.
Dillard's reported Q3 2026 net income of $130.9 million, or $8.38 per share, on total retail sales of $1.418 billion. The company achieved 1% comparable store sales growth and maintained a strong retail gross margin of 45.3%.
Term
Q3 2026
“We achieved 1% sales growth on top of last year’s 3% increase, supporting a strong 45.3% retail gross margin. As we head into the holidays, our stores and dedicated team are ready to welcome and serve our customers.”
Nakamoto Inc. reported a net income of $85.5 million for the quarter ended September 30, 2026, a significant recovery from an $86.0 million loss in the prior year, primarily driven by a $110.4 million gain on the fair value of digital assets. However, the company faces a year-to-date net loss of $286.2 million due to substantial goodwill impairment and non-operating expenses earlier in the year.
NeuroPace reported a decrease in total assets from $105.6 million at the end of 2025 to $94.8 million as of September 30, 2026, primarily driven by a reduction in cash and short-term investments. The company maintains a significant accumulated deficit of $568.6 million and expects to lose its emerging growth company status on December 31, 2026.
SmartStop Self Storage REIT Capital Raise of $334M
SmartStop Self Storage REIT entered into forward sale agreements for an aggregate of 9,372,500 shares of common stock at an initial forward price of $35.6125 per share. The offering includes 8,150,000 initial shares and 1,222,500 shares from the full exercise of the underwriters' overallotment option. The company intends to use the net proceeds from the eventual settlement of these agreements to fund pending investments, including a Canadian joint venture and potential acquisitions.
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.64M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $584.20 to $598.63 a share (average $593.99) in 14 transactions, worth $5.64M in total on Nov 11, 2026. Shares held after the trade: 324,443 (-0.1%).
Amkor Technology CFO Megan Faust Sells $35K of Stock
Megan Faust, CFO, sold 1,000 shares of Amkor Technology, Inc. at $35.00 a share, worth $35K in total on Nov 10, 2026. Shares held after the trade: 132,105 (-0.8%).
GAXOS.AI INC. reported a significant revenue increase to $7.08 million for the nine months ended September 30, 2026, compared to $0.69 million in the prior year, driven by a $1.75 million gain on the sale of gaming assets. Despite the revenue growth, the company incurred a net loss attributable to common shareholders of $2.86 million due to a substantial rise in selling, general, and administrative expenses.
David Buonasera, CTO, sold 871 shares of Magnite, Inc. at $29.00 a share, worth $25.3K in total on Nov 9, 2026. Shares held after the trade: 238,578 (-0.4%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.57M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $577.52 to $592.93 a share (average $586.32) in 14 transactions, worth $5.57M in total on Nov 10, 2026. Shares held after the trade: 324,443 (-0.0%).
Liquidmetal Technologies reported a net loss of $2.37 million for the nine months ended September 30, 2026, compared to $1.64 million in the prior year period. While product revenue increased slightly to $674 thousand, the company faced higher operating expenses and a $220 thousand loss on the disposal of property and equipment.
American National Group Inc. reported net income attributable to common stockholders of $939 million for the third quarter of 2026, a significant increase from $208 million in the prior year period. Total assets remained stable at $130.5 billion, while total equity decreased to $8.1 billion primarily due to a $2.2 billion unrealized investment loss recorded in other comprehensive income.
For the nine months ended September 30, 2026, Commonwealth Credit Partners BDC I, Inc. reported total investment income of $45.8 million and net investment income of $35.5 million, both down from the prior year period. Net asset value per share decreased to $866.13 from $895.75 at year-end 2025, primarily driven by $17.2 million in net unrealized losses on investments.
Brian Gephart, CFO, sold 3,700 shares of Magnite, Inc. at $28.78 a share, worth $106K in total on Nov 9, 2026. Shares held after the trade: 163,310 (-2.2%).
Advanced Drainage Systems M&A Deal with StormTrap Investments LLC
Advanced Drainage Systems, Inc. (ADS) has completed its acquisition of StormTrap Investments LLC from PSP Capital. The deal expands ADS's addressable market in highly engineered stormwater storage solutions and provides cross-selling opportunities within the water management industry.
Bain Capital Private Credit reported total investment income of $173.3 million for the nine months ended September 30, 2026, a significant increase from $88.3 million in the prior year period. Net investment income grew to $83.1 million as the company expanded its investment portfolio to $2.4 billion at fair value, up from $1.68 billion at the end of 2025.
AIM ImmunoTech reported a net loss of $9.95 million for the nine months ended September 30, 2026, compared to $9.78 million in the prior year. The company significantly strengthened its balance sheet through equity offerings and warrant exercises, increasing total assets to $9.75 million and achieving a positive stockholders' equity of $7.08 million.
SES AI Corp reported total current assets of $161.6 million as of September 30, 2026, a decrease from $216.3 million at year-end 2025, primarily driven by a reduction in short-term investments. The company continues to incur losses and highlights risks related to its drone cell manufacturing, AI-based services, and the integration of UZ Energy.
Industrial Logistics Properties Trust Insider Kevin C. Phelan Buys $12K of Stock
Kevin C. Phelan bought 2,000 shares of Industrial Logistics Properties Trust at $6.01 a share, worth $12K in total on Nov 9, 2026. Shares held after the trade: 9,500 (+26.7%).
Journey Medical Corp reported a 16.7% increase in total revenue to $53.4 million for the nine months ended September 30, 2026, compared to the prior year. The company significantly reduced its net loss from $10.2 million to $3.9 million over the same period, driven by improved operating margins and lower research and development expenses.